Urogenital mixed infection: what causes Mycoplasma Genitalia
Jul 02, 2018
Cystitis and pyelonephritis have become literally common diseases - for sure, every person encountered them and even underwent treatment.Many relate to such diseases somewhat disorderly and begin to take any action only during the aggravation of their symptoms.But even such periodic receptions of medicines do not lead to complete recovery - as soon as the symptoms disappear, the treatment ends with the patient himself.Meanwhile, doctors say that these mixed infections are dangerous to health and they must be fully treated.Table of contents: What is a mixed infection What causes mycoplasma Genitalia?
What is a mixed infection
By this term, doctors mean an infectious disease that is caused not by one but by several pathogenic microorganisms - the disease in this case develops along a single pathogenesis pathway.It is not just a matter of combining several different types of pathogens, it is important to take into account their "commonwealth", which has some peculiarities and leads to serious consequences in the absence of treatment.
As for the urogenital tract, most often it is affected by three types of pathogens - Ureaplasma urealyticum , , Mycoplasma hominis , M. genitalium , which are identified as a whole.It is interesting that the pathogenicity of M. genitalium is not in doubt by anyone, but two other types of microorganisms are still considered conditionally pathogenic.Many scientists and doctors claim that these microorganisms are present in every organism and do not pose any danger to health, but as soon as the third species( M. genitalium) joins them, the pathology begins to develop.
What causes mycoplasma Genitalia?
Most often, under the influence of the microorganism M. genitalium( Mycoplasma Genitalium), women develop internal genital diseases - salpingoophoritis, endocervicitis, as well as pathologies of other internal organs and systems, the most diagnosed in this case is pyelonephritis.
EndocercivitisRecommended to read:
The disease is an inflammatory process that occurs in the mucous membrane of the cervical canal of the uterus.Symptomatology of this disease is quite pronounced, but not characteristic - the pains in the lower abdomen are different( noisy and sharp, paroxysmal and persistent) and abundant discharge from the vagina.
Endocercivitis poses a danger to a woman - with the penetration of infection directly into the body of the uterus, serious violations in the reproductive function of the reproductive system of women can develop.This disease is extremely dangerous in case of its progression in the period of pregnancy already taken place - consequences can be miscarriages, premature births, atypical development of the fetus.
Salpingo-oophoritisRecommended to read:
This inflammation occurs in the ovaries and fallopian tubes.The clinical picture with this disease is almost absent - a woman can pay attention only to periodic, short-term and not intense pain in the lower abdomen and / or lower back.
Salpingoophoritis is dangerous due to the development of a commissural disease, which is a provoker of female infertility.Put this diagnosis in time is almost impossible and most often the patient starts to know about salpingo-oophoritis and adhesions only when the causes of infertility are clarified.
This is the classification of the inflammatory process that develops in the calyx-pelvis kidney system.
Symptomatic of pyelonephritis is always pronounced:
- the temperature rises to 38-40 degrees;
- there are pains in the lumbar region and in the lower abdomen, characterized by intensity;
- patient is concerned about chills and fever;
- occasionally have nausea and vomiting.
Bacterial kidney damage leads to serious complications, which can even lead to the need for complex surgical intervention.A chronic pyelonephritis is treated for a very long time, the patient is forced to take a large number of medications and constantly adhere to strict / serious restrictions in nutrition.Recommendations:
Principles of treatment of urogenital mixed infection
When choosing medicines for the treatment of urogenital mixed infections, doctors take into account the fact that pathogens are pathogenic microorganisms that "live" in the cells of the body.Therefore, for successful recovery, it is necessary to take such drugs, the active substances of which are able to accumulate in cells and have a lasting effect on pathogenic microorganisms.
Note: has recently observed the immunity of pathogenic microorganisms that cause urogenital mixed infections, to tetracycline drugs and macrolides - they are almost never used in the treatment of these diseases.
To ensure that the choice of antibacterial drugs is correct, doctors should refer the patient to a microbiological examination of the smear and PCR-such tests can identify a particular pathogen and select an effective drug.
Another important point: treatment of urogenital mixed infections should always take place in several stages, which is due to the combination of different types of pathogenic microorganisms( pathogens).
General principles of treatment of urogenital mixed infection:
- The first stage is the course of taking drugs from the category "anti-trichomonation therapy" .
- Strengthening the immunity of and normalization of local microflora - it is necessary to control conditionally pathogenic microorganisms that are constantly present in the vagina of a woman.Otherwise, another pathology may join the already existing diseases.
- Treatment of both partners is mandatory .If the therapy is only for a woman, the recurrence of the disease is unavoidable, since during sexual intercourse the conditionally pathogenic microorganisms will again find themselves in the woman's vagina.This is the way of systemic infection and the chronic forms of the considered diseases, related to urogenital mixed infections, develop.
Urogenital mixed infections are not a temporary deterioration in health, but rather serious diseases that can lead to infertility, chronic inflammatory processes.Only full and correct treatment will prevent the development of complications.
Tsygankova Yana Aleksandrovna, medical reviewer, therapeutist of the highest qualification category